Expert Opinion on Emerging Drugs

Papers
(The TQCC of Expert Opinion on Emerging Drugs is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Injectable, oral, gene-based, and vaccine-driven PCSK9-targeted therapies: emerging clinical insights shaping the future of hypercholesterolemia management34
Emerging immune tolerance therapies for neuromyelitis optica spectrum disorder25
Emerging and traditional 5-α reductase inhibitors and androgen receptor antagonists for male androgenetic alopecia22
Combined chemo-immunotherapy in advanced non-small cell lung cancer: feasible in the elderly?22
New drugs targeting calcitonin gene-related peptide for the management of migraines18
A review of phase II and III drugs for the treatment and management of endometriosis18
Emerging drugs for the treatment of acne: a review of phase 2 & 3 trials16
Evolving role of VIADISC for chronic low back and discogenic pain: a narrative review15
Emerging injectable therapies for osteoarthritis14
Emerging drugs for the treatment of progressive familial intrahepatic cholestasis: a focus on phase II and III trials14
How can we prevent diarrhea induced by systemic treatments in oncological patients? An evaluation of phase II trials14
Muscarinic M1 and M4 agents as treatments for schizophrenia: what do they do and who do they do it for?13
Emerging biological treatments for asthma12
Existing and emerging therapies for the treatment of invasive candidiasis and candidemia12
Emerging medicines to improve the basic defect in cystic fibrosis12
Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape11
Emerging treatment for Sjögren’s disease: a review of recent phase II and III trials10
Newly emerging tyrosine kinase inhibitors for the treatment of neuroendocrine neoplasms10
Emerging drugs for the treatment of herpetic keratitis9
Cannabinoid treatment for the symptoms of autism spectrum disorder9
A review of emerging factor XI inhibitors9
A comprehensive review of phase 2/3 trials in osteoarthritis: an expert opinion8
Emerging monoclonal antibody therapies in the treatment of metastatic urothelial carcinoma8
Emerging tyrosine kinase inhibitors for head and neck cancer8
ONC201 (Dordaviprone): review of evidence to date in diffuse midline glioma, hope or hype?8
Correction8
Emerging antiviral therapies and drugs for the treatment of influenza8
Emerging drugs in phase II and III clinical development for the treatment of alcohol use disorder8
0.16214394569397